Journal of Clinical Oncology, Vol 20, Issue 4
(February), 2002: 900-910
© 2002 American Society for Clinical Oncology
Aberrant p53 Expression Correlates With Expression of Vascular Endothelial Growth Factor mRNA and Interleukin-8 mRNA and Neoangiogenesis in Non–Small-Cell Lung Cancer
By Ang Yuan,
Chong-Jen Yu,
Kwen-Tay Luh,
Sow-Hsong Kuo,
Yung-Chie Lee,
Pan-Chyr Yang
From the Division of Chest Medicine, Department of Internal Medicine; Division of Chest Surgery, Department of Surgery; and Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, and Institute of Biomedical Sciences, Academia Sinica, Taiwan.
Address reprint requests to Pan-Chyr Yang, MD, PhD, National Taiwan University Hospital, No 7, Chung-Shan South Rd, Taipei 100, Taiwan; email: pcyang{at}ha.mc.ntu.edu.tw
PURPOSE: To evaluate interactions between expressions of tumor suppressor gene p53 and angiogenic factors vascular endothelial cell growth factor (VEGF) and interleukin-8 (IL-8) and their effect on tumor angiogenesis and patient prognosis in non–small-cell lung cancer (NSCLC).
PATIENTS AND METHODS: p53, VEGF, IL-8, and the microvessel endothelium were immunostained, and VEGF and IL-8 mRNA expression were quantified using the real-time quantitative reverse-transcription polymerase chain reaction in 65 NSCLC surgical specimens. Aberrant p53 expression was correlated with VEGF and IL-8 mRNA expression, microvessel count (MVC), other clinical-pathologic variables, and patients’ survival.
RESULTS: Tumors with high aberrant p53 expression showed significantly higher VEGF and IL-8 mRNA expression and MVC than those with low aberrant p53 expression (P < .001). When tested as a continuous variable, aberrant p53 expression correlated strongly and positively with VEGF and IL-8 mRNA expression and MVC (P < .0001). Tumors with high aberrant p53 expression were associated with mediastinal or distant lymph node metastasis (P = .006). Survival and postoperative relapse time were significantly shorter in patients with high aberrant p53 expression tumors than in those with low aberrant expression tumors (P < .0001). A significant difference in survival was also seen between patients with high and low tumoral VEGF mRNA expression and between those with high and low tumoral IL-8 mRNA expression (P < .0001).
CONCLUSION: We report here for the first time that aberrant p53 expression is strongly positively correlated with VEGF mRNA and IL-8 mRNA expression in NSCLC. This result indicates that aberrant p53 expression may play a significant role in regulation of VEGF and IL-8 expression and be involved in controlling angiogenesis and explains the adverse prognosis of cancers with high aberrant p53 expression.
Supported in part by grant no. NSC-89-2314-B-002-425 from the National Science Council of the Republic of China.
This article has been cited by other articles:
|
|
|
|
 
S. Luxen, S. A. Belinsky, and U. G. Knaus
Silencing of DUOX NADPH Oxidases by Promoter Hypermethylation in Lung Cancer
Cancer Res.,
February 15, 2008;
68(4):
1037 - 1045.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Colla, S. Tagliaferri, F. Morandi, P. Lunghi, G. Donofrio, D. Martorana, C. Mancini, M. Lazzaretti, L. Mazzera, L. Ravanetti, et al.
The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 {alpha} (HIF-1{alpha}) activity: involvement in myeloma-induced angiogenesis
Blood,
December 15, 2007;
110(13):
4464 - 4475.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Yasuda, K. Nakayama, M. Watanabe, S. Suzuki, H. Fuji, S. Okinaga, A. Kanda, K. Zayasu, T. Sasaki, M. Asada, et al.
Nitroglycerin Treatment May Enhance Chemosensitivity to Docetaxel and Carboplatin in Patients with Lung Adenocarcinoma.
Clin. Cancer Res.,
November 15, 2006;
12(22):
6748 - 6757.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Tsubochi, N. Sato, M. Hiyama, M. Kaimori, S. Endo, Y. Sohara, and T. Imai
Combined Analysis of Cyclooxygenase-2 Expression With p53 and Ki-67 in Nonsmall Cell Lung Cancer.
Ann. Thorac. Surg.,
October 1, 2006;
82(4):
1198 - 1204.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Taguchi, N. Ohmiya, K. Shirai, N. Mabuchi, A. Itoh, Y. Hirooka, Y. Niwa, and H. Goto
Interleukin-8 Promoter Polymorphism Increases the Risk of Atrophic Gastritis and Gastric Cancer in Japan
Cancer Epidemiol. Biomarkers Prev.,
November 1, 2005;
14(11):
2487 - 2493.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P.-L. Yao, Y.-C. Lin, C.-H. Wang, Y.-C. Huang, W.-Y. Liao, S.-S. Wang, J. J. W. Chen, and P.-C. Yang
Autocrine and Paracrine Regulation of Interleukin-8 Expression in Lung Cancer Cells
Am. J. Respir. Cell Mol. Biol.,
June 1, 2005;
32(6):
540 - 547.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Pietrowski, H. Bettendorf, E.-K. Riener, C. Keck, L. A. Hefler, J. C. Huber, and C. Tempfer
Recurrent pregnancy failure is associated with a polymorphism in the p53 tumour suppressor gene
Hum. Reprod.,
April 1, 2005;
20(4):
848 - 851.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Hoeben, B. Landuyt, M. S. Highley, H. Wildiers, A. T. Van Oosterom, and E. A. De Bruijn
Vascular Endothelial Growth Factor and Angiogenesis
Pharmacol. Rev.,
December 1, 2004;
56(4):
549 - 580.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. H. Benoy, R. Salgado, P. Van Dam, K. Geboers, E. Van Marck, S. Scharpe, P. B. Vermeulen, and L. Y. Dirix
Increased Serum Interleukin-8 in Patients with Early and Metastatic Breast Cancer Correlates with Early Dissemination and Survival
Clin. Cancer Res.,
November 1, 2004;
10(21):
7157 - 7162.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Besse, C. Cande, J.-P. Spano, A. Martin, D. Khayat, T. Le Chevalier, T. Tursz, L. Sabatier, J.-C. Soria, and G. Kroemer
Nuclear Localization of Apoptosis Protease Activating Factor-1 Predicts Survival after Tumor Resection in Early-Stage Non-Small Cell Lung Cancer
Clin. Cancer Res.,
September 1, 2004;
10(17):
5665 - 5669.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. V. Bobrovnikova-Marjon, P. L. Marjon, O. Barbash, D. L. Vander Jagt, and S. F. Abcouwer
Expression of Angiogenic Factors Vascular Endothelial Growth Factor and Interleukin-8/CXCL8 Is Highly Responsive to Ambient Glutamine Availability: Role of Nuclear Factor-{kappa}B and Activating Protein-1
Cancer Res.,
July 15, 2004;
64(14):
4858 - 4869.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Hopfl, O. Ogunshola, and M. Gassmann
HIFs and tumors--causes and consequences
Am J Physiol Regulatory Integrative Comp Physiol,
April 1, 2004;
286(4):
R608 - R623.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Pold, L. X. Zhu, S. Sharma, M. D. Burdick, Y. Lin, P. P. N. Lee, A. Pold, J. Luo, K. Krysan, M. Dohadwala, et al.
Cyclooxygenase-2-Dependent Expression of Angiogenic CXC Chemokines ENA-78/CXC Ligand (CXCL) 5 and Interleukin-8/CXCL8 in Human Non-Small Cell Lung Cancer
Cancer Res.,
March 1, 2004;
64(5):
1853 - 1860.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Zhang, N. Yang, D. Katsaros, W. Huang, J.-W. Park, S. Fracchioli, C. Vezzani, I. A. Rigault de la Longrais, W. Yao, S. C. Rubin, et al.
The Oncogene Phosphatidylinositol 3'-Kinase Catalytic Subunit {alpha} Promotes Angiogenesis via Vascular Endothelial Growth Factor in Ovarian Carcinoma
Cancer Res.,
July 15, 2003;
63(14):
4225 - 4231.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Abe, K. Terada, H. Wakimoto, R. Inoue, E. Tyminski, R. Bookstein, J. P. Basilion, and E. A. Chiocca
PTEN Decreases in Vivo Vascularization of Experimental Gliomas in Spite of Proangiogenic Stimuli
Cancer Res.,
May 1, 2003;
63(9):
2300 - 2305.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. S. White, K. R. Flaherty, S. Carskadon, A. Brant, M. D. Iannettoni, J. Yee, M. B. Orringer, and D. A. Arenberg
Macrophage Migration Inhibitory Factor and CXC Chemokine Expression in Non-Small Cell Lung Cancer: Role in Angiogenesis and Prognosis
Clin. Cancer Res.,
February 1, 2003;
9(2):
853 - 860.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. J. Freemantle and E. Dmitrovsky
Clinical Link Between p53and Angiogenesis in Lung Cancer
J. Clin. Oncol.,
February 15, 2002;
20(4):
883 - 884.
[Full Text]
[PDF]
|
|
|
|
